Main Article Content
Background. The problem of impairment of bone mineral density (BMD) in postmenopausal women is relevant due to a high risk of osteoporotic fractures, especially against the comorbid pathology. The aim of the study was to assess the impact of diabetes mellitus (DM) type 2 on the bone mineral density in postmenopausal women of different age depending on DM duration and type of antiglycemic treatment. Materials and methods. BMD was studied in 38 postmenopausal patients with DM type 2 (average age 64.36 ± 1.95 years old, average duration of DM type 2 10.68 ± 1.88 years, average glycated hemoglobin 9.02 ± 0.29 %). BMD state was measured by dual energy X-ray absorptiometry. BMD was estimated using T-criteria. Results. Postmenopausal women without DM were found to have decreases BMD with aging by T-criteria. T-criteria of lumbar spine L1–L4 I women aged 50–59 years old was –0.24 ± –0.22 that confirms osteopenia. In women aged 60–69 years old T-criteria was –2.20 ± –0.22 that confirms osteoporosis. The age changes of average values of T-criteria in DM type 2 were found to be less negative compared with a control group, but worse densitometric parameters on L1–L4 level at the age ≤ 60 years old (–0.71 ± –0.09 vs –0.24 ± –0.02 (P < 0.001). Conclusion. BMD in postmenopausal women with DB type 2 and without DM assessed by T-criteria decreased in all regions with aging. Postmenopausal women with DB type 2 had worse densitometric parameters by T-criteria on L1–L4 level at the age ≤ 60 years old. With increasing DB duration over 10 years densitomentric density of femoral neck reduces, and lumbar spine BMD by T-criteria are inverse. Insulin therapy does not improve femoral BMD by T-criteria, however positive effect of insulin therapy improves state of lumbar spine.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Atanova YaO, Kyryliuk ML. Effects of type 2 diabetes mellitus on bone metabolism in postmenopausal women. Healh of Woman. 2016;3(109):115-119 (Ukrainian).
Vayda VM. Bone mineral density of the spine in women of different ages. Litopys travmotolohiyi ta ortopediyi. 2011;1-2:244-245. (Ukrainian).
Kyryliuk ML, Atanova YaO. State of the bone hormonal functions in postmenopausal women with type 2 diabetes. Clinical Endocrinology and Endocrine Surgery. 2016;2(54):62-67. (Ukrainian)
Kyryliuk ML, Atanova YaO, Tretiak OE. Phosphorus and calcium metabolism in postmenopausal women with diabetes mellitus: effects of the type and duration of the disease, time of menopause and body mass. International Journal of Endocrinology. 2016;1(73):87-91 (Ukrainian).
Mkrtumyan AM. Modern possibilities of solving the problem of osteoporosis in patients with type 2 diabetes. Effektivnaya farmakoterapiya. 2014;53:70-76 (Russian).
Musienko AS. Bone mineral density and FRAX parameters in postmenopausal women. Bol'. Sustavy. Pozvonochnik. 2012;1(05) (Ukrainian).
Ma L. et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur. J. Epidemiol. 2012;27:319–332.
Gorman E. et al. Bone health and type 2 diabetes mellitus: a systematic review. Physiother. Can. 2011;63(1):8-20.
Rakic V, Davis WA, Chubb SA, Islam FM. et al. Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia. 2006;49(5):863–871.
Hampson G. et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia. 1998;41:1314-1320.
Adil C. et al. Bone mineral density evaluation of patients with type 2 diabetes mellitus. J. Phys. Ther. Sci. 2015;27(1):179-82.
Weinstock RS. et al. Bone mineral density in women with type II diabetes mellitus. J. Bone Miner. Res. 1989;4:97-101.
Sosa M. et al. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus. J. Diabetes Complications. 1996;10:201-205.
Brown JP, Josse RG. Сlinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can. Med. Assoc. J. 2002;167(Suppl.10):1-34.
Majima T, Komatsu Y, Yamada T, Koike Y. et al. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos. Int. 2005;16:907-913.
Gerdhem P. et al. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos. Int. 2005;16:1506-1512.
Johnston CCJr, Hui SL, Longcope C. Bone mass and sex steroid concentrations in postmenopausal Caucasian diabetics. 1985;34:544-550.
Zhou Y. et al. Prevalence and predic-tors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. J. Diabetes Res. Clin. Pract. 2010;90:261-269.
Sayers A, Lawlor DA, Sattar N, Tobias JH. The association between insulin levels and cortical bone: findings from a cross-sectional analysis of pQCT parameters in adolescents. Journal of Bone and Mineral Research. 2012;27(3):610-618.
Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis. Osteoporos. Int. 2007;18:427-444.